Paclitaxel: An Update of its Use in the Treatment of Metastatic Breast Cancer and Ovarian and Other Gynaecological Cancers

Author： Wiseman L.R.   Spencer C.M.  

Publisher： Adis International

ISSN： 1170-229X

Source： Drugs & Aging, Vol.12, Iss.4, 1998-04, pp. : 305-334

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Paclitaxel: A Pharmacoeconomic Review of its Use in the Treatment of Ovarian Cancer

By Young M.   Plosker G.L.  

PharmacoEconomics, Vol. 19, Iss. 12, 2001-01 ,pp. : 1227-1259

Adis International

Access to resources Recommend Favorite

Docetaxel: A Pharmacoeconomic Review of its Use in the Treatment of Metastatic Breast Cancer

By Lamb H.M.   Wiseman L.R.  

PharmacoEconomics, Vol. 14, Iss. 4, 1998-10 ,pp. : 447-459

Adis International

Access to resources Recommend Favorite

Bevacizumab: A Review of its Use in Combination with Paclitaxel or Capecitabine as First-Line Therapy for HER2-Negative Metastatic Breast Cancer

By Croom Katherine F.   Dhillon Sohita  

Drugs, Vol. 71, Iss. 16, 2011-11 ,pp. : 2213-2229

Adis International

Access to resources Recommend Favorite

Docetaxel: A Review of its Use in Metastatic Breast Cancer

By Lyseng-Williamson Katherine A.   Fenton Caroline  

Drugs, Vol. 65, Iss. 17, 2005-01 ,pp. : 2513-2531

Adis International

Access to resources Recommend Favorite

Docetaxel: An Update of its Use in Advanced Breast Cancer

By Figgitt D.P.   Wiseman L.R.  

Drugs, Vol. 59, Iss. 3, 2000-03 ,pp. : 621-651

Adis International

Access to resources Recommend Favorite